Michael B Hoffman's Net Worth

$728 Thousand

Estimate Recalculated Jul 12, 2024 03:03PM EST

Who is Michael B Hoffman?

Michael B Hoffman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Northern Genesis Acquisition Corp. III, Northern Genesis Acquisition Corp. II, Enviva Partners, LP, Annovis Bio, Inc., BUCKEYE PARTNERS L P, Onconova Therapeutics, Inc., Talen Energy Corp, Pattern Energy Group Inc., Northern Genesis Acquisition Corp., and Buckeye GP Holdings L.P..

SEC CIK

Michael B Hoffman's CIK is 0001290208

Past Insider Trading and Trends

2013 was Michael B Hoffman's most active year for acquiring shares with 18 total transactions. Michael B Hoffman's most active month to acquire stocks was the month of June. 2013 was Michael B Hoffman's most active year for disposing of shares, totalling 9 transactions. Michael B Hoffman's most active month to dispose stocks was the month of June. 2013 saw Michael B Hoffman paying a total of $15,367,563.00 for 3,770,370 shares, this is the most they've acquired in one year. In 2006 Michael B Hoffman cashed out on 11,100 shares for a total of $484,522.77, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Northern Genesis Acquisition Corp. III No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Northern Genesis Acquisition Corp. II No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Enviva Partners, LP (EVA) Snapshot price: $0.458

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Annovis Bio, Inc. (ANVS) Snapshot price: $10.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 17
Form 4/A
+275.54%
163.88K
$6.10
$999,668.00
223.36K
Nov 20
Form 4
+276.99%
164.75K
$6.07
$1,000,002.15
224.22K
Nov 20
Form 4
∞
59.48K
$12.61
$750,004.97
59.48K
Apr 7
Form 4
—
0
—
—
0
Jan 18
Form 4
+2.19%
30.39K
$11.69
$10.06
1.42M
Jan 3 - Jan 4
Form 4
—
0
—
—
0
Jul 7
Form 4/A
—
0
—
—
0
Jul 1
Form 4
+9,701.03%
1.39M
$5.25
—
1.4M
Jan 31
Form 3
—
0
—
—
0
No matching records found

BUCKEYE PARTNERS L P No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-11.10K
$43.65
-$484,522.77
0
Sep 20
Form 4
+400.00%
11.1K
$44.71
$496,269.91
13.88K
Jun 8
Form 3
—
0
—
—
0
No matching records found